Show simple item record

dc.contributor.authorHashemi, H
dc.contributor.authorNamazi, H
dc.date.accessioned2018-08-26T06:35:31Z
dc.date.available2018-08-26T06:35:31Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/44212
dc.description.abstractA new blue fluorescent surface modified graphene oxide (GO) by 6-(5-bromothiophen-2-yl) benzo[c][1,2,5]selenadiazole-5-carboxylic acid (TB) denoted as (GO-TB) was synthesized. The obtained hybrid was characterized by Scanning Electron Microscope (SEM/EDS); Brunauer-Emmett-Teller (BET); X-Ray Diffraction Spectroscopy (XRD); X-Ray Photoelectron Spectroscopy (XPS); UV-Vis Absorption Spectroscopy, and Fourier Transformed Infrared Spectroscopy (FTIR). The synthesized TB moiety displayed orange emission around 590 nm, while GO-TB exhibited a blue photoluminescence around 431 and 159 nm blue shift of photoluminescence. Doxorubicin immobilized on the hybrid surface up to 93%, and the release behavior in three different pHs was investigated. The release profile indicated a pH-dependent liberation with Fickian diffusion mechanism. The cytotoxicity of the hybrid was studied and the IC50 value for the hybrid was 5.16 A mu g/ml.
dc.language.isoEnglish
dc.relation.ispartofAPPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
dc.titleSynthesis and characterization of blue fluorescent surface modified nano-graphene oxide flakes as a pH-sensitive drug delivery system
dc.typeArticle
dc.citation.volume124
dc.citation.issue7
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1007/s00339-018-1898-5


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record